PT2874604T - Utilização de um agente quelante anfótero para a prevenção das alergias de contacto - Google Patents
Utilização de um agente quelante anfótero para a prevenção das alergias de contactoInfo
- Publication number
- PT2874604T PT2874604T PT137474524T PT13747452T PT2874604T PT 2874604 T PT2874604 T PT 2874604T PT 137474524 T PT137474524 T PT 137474524T PT 13747452 T PT13747452 T PT 13747452T PT 2874604 T PT2874604 T PT 2874604T
- Authority
- PT
- Portugal
- Prior art keywords
- chelating agent
- preventing contact
- contact allergies
- amphoteric chelating
- amphoteric
- Prior art date
Links
- 206010020751 Hypersensitivity Diseases 0.000 title 1
- 230000007815 allergy Effects 0.000 title 1
- 239000002738 chelating agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/51—Chelating agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Preventing Corrosion Or Incrustation Of Metals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1256939A FR2993466B1 (fr) | 2012-07-18 | 2012-07-18 | Utilisation d'une creme de protection contre les effets des agents chimiques agressifs en contact avec la peau |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2874604T true PT2874604T (pt) | 2018-05-11 |
Family
ID=47137836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT137474524T PT2874604T (pt) | 2012-07-18 | 2013-07-17 | Utilização de um agente quelante anfótero para a prevenção das alergias de contacto |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US11197874B2 (pt) |
| EP (2) | EP2874661B1 (pt) |
| CN (4) | CN104470501A (pt) |
| AU (2) | AU2013291793B2 (pt) |
| BR (2) | BR112015001019B1 (pt) |
| CA (2) | CA2878650C (pt) |
| DK (2) | DK2874661T3 (pt) |
| ES (2) | ES2690060T3 (pt) |
| FR (1) | FR2993466B1 (pt) |
| IN (1) | IN2014DN10924A (pt) |
| MX (2) | MX356811B (pt) |
| NO (1) | NO2874604T3 (pt) |
| NZ (2) | NZ703409A (pt) |
| PL (2) | PL2874661T3 (pt) |
| PT (1) | PT2874604T (pt) |
| SI (1) | SI2874661T1 (pt) |
| TR (1) | TR201815143T4 (pt) |
| WO (2) | WO2014013194A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3093001B1 (fr) * | 2019-02-22 | 2022-06-10 | Prevor Int | Composition pour enlever des residus chimiques et ses utilisations |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2604900B1 (fr) * | 1986-10-08 | 1989-01-13 | Blomet Marie Claude | Solution physiologique pour le lavage des parties du corps humain ayant ete mises en contact avec un acide fluorhydrique et concentre pour sa preparation |
| US5091171B2 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
| US5587400A (en) * | 1993-04-19 | 1996-12-24 | Marie-Claude Blomet epouse Meyer | Physiological composition for the treatment of thermal or chemical burns |
| US5665804A (en) * | 1996-02-05 | 1997-09-09 | Dow Corning Corporation | Silicone latex solvent thickening |
| SE9604610D0 (sv) * | 1996-12-16 | 1996-12-16 | Noviscens Ab | Medical composition |
| US6242042B1 (en) * | 1998-09-14 | 2001-06-05 | Lrc Products Ltd. | Aqueous coating composition and method |
| US6582683B2 (en) * | 2000-01-04 | 2003-06-24 | Skinvisible Pharmaceuticals, Inc. | Dermal barrier composition |
| FR2809959B1 (fr) * | 2000-06-07 | 2004-10-29 | Marie Claude Meyer | Utilisation d'un complexe d'aluminium et de ligand ethylenediamine-tetraacetique pour la prevention et/ou le traitement des urticaires |
| GB0403702D0 (en) * | 2004-02-19 | 2004-03-24 | Boots Co Plc | Skincare compositions |
| US20070232681A1 (en) * | 2003-10-14 | 2007-10-04 | Oxagen Limited | Compounds Having Crth2 Antagonist Activity |
| GB0324084D0 (en) * | 2003-10-14 | 2003-11-19 | Oxagen Ltd | Compounds |
| EP1851669B1 (en) * | 2005-02-02 | 2015-07-08 | POCRASS, Alan L. | Data storage and transfer device and method |
| EP2238183B1 (en) * | 2008-01-18 | 2019-02-27 | Vystar Corporation | Natural rubber latex having reduced allergenicity and method of making |
| WO2011041680A2 (en) * | 2009-10-02 | 2011-04-07 | The Brigham And Women's Hospital, Inc. | Compositions and methods of prophylaxis for contact dermatitis |
-
2012
- 2012-07-18 FR FR1256939A patent/FR2993466B1/fr active Active
-
2013
- 2013-07-17 CA CA2878650A patent/CA2878650C/fr active Active
- 2013-07-17 WO PCT/FR2013/051717 patent/WO2014013194A1/fr active Application Filing
- 2013-07-17 PL PL13747451T patent/PL2874661T3/pl unknown
- 2013-07-17 NO NO13747452A patent/NO2874604T3/no unknown
- 2013-07-17 NZ NZ703409A patent/NZ703409A/en unknown
- 2013-07-17 CN CN201380037698.8A patent/CN104470501A/zh active Pending
- 2013-07-17 CN CN201380037758.6A patent/CN104507501A/zh active Pending
- 2013-07-17 BR BR112015001019-9A patent/BR112015001019B1/pt active IP Right Grant
- 2013-07-17 DK DK13747451.6T patent/DK2874661T3/en active
- 2013-07-17 AU AU2013291793A patent/AU2013291793B2/en active Active
- 2013-07-17 PL PL13747452T patent/PL2874604T3/pl unknown
- 2013-07-17 EP EP13747451.6A patent/EP2874661B1/fr active Active
- 2013-07-17 TR TR2018/15143T patent/TR201815143T4/tr unknown
- 2013-07-17 EP EP13747452.4A patent/EP2874604B1/fr active Active
- 2013-07-17 CN CN201810186400.4A patent/CN108606964A/zh active Pending
- 2013-07-17 WO PCT/FR2013/051718 patent/WO2014013195A1/fr active Application Filing
- 2013-07-17 US US14/415,146 patent/US11197874B2/en active Active
- 2013-07-17 US US14/415,428 patent/US10953024B2/en active Active
- 2013-07-17 CN CN201910485746.9A patent/CN110179686A/zh active Pending
- 2013-07-17 BR BR112015001018-0A patent/BR112015001018B1/pt active IP Right Grant
- 2013-07-17 IN IN10924DEN2014 patent/IN2014DN10924A/en unknown
- 2013-07-17 AU AU2013291792A patent/AU2013291792B2/en active Active
- 2013-07-17 MX MX2015000786A patent/MX356811B/es active IP Right Grant
- 2013-07-17 DK DK13747452.4T patent/DK2874604T3/en active
- 2013-07-17 SI SI201331206T patent/SI2874661T1/sl unknown
- 2013-07-17 ES ES13747451.6T patent/ES2690060T3/es active Active
- 2013-07-17 CA CA2878882A patent/CA2878882C/fr active Active
- 2013-07-17 NZ NZ703258A patent/NZ703258A/en unknown
- 2013-07-17 MX MX2015000785A patent/MX359747B/es active IP Right Grant
- 2013-07-17 ES ES13747452.4T patent/ES2667709T3/es active Active
- 2013-07-17 PT PT137474524T patent/PT2874604T/pt unknown
-
2021
- 2021-02-10 US US17/172,434 patent/US20210275553A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2992093T3 (pl) | Środek czyszczący zawierający proteazy | |
| AP4029A (en) | Inhibitors of beta-secretase | |
| IL233596A0 (en) | A method to prevent allergies | |
| HK1214269A1 (zh) | 肌萎縮側索硬化症 治療 | |
| HK1206620A1 (en) | Therapeutic agent for dyslipidemia | |
| HK1211947A1 (en) | Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitors | |
| HK1208173A1 (en) | Bromocriptine formulations | |
| HUE051648T2 (hu) | CCR3-gátlók használata | |
| EP2940497A4 (en) | POLARIZING MASK | |
| HK1201252A1 (en) | Modified blasting agent | |
| EP2937099A4 (en) | APOPOTOSIS INDUCING AGENT | |
| HK1206976A1 (en) | Composition for agent for external use | |
| IL236963A0 (en) | beta-secretase inhibitors | |
| HK1201066A1 (en) | Pyranopyridone inhibitors of tankyrase | |
| HK1214152A1 (zh) | 用於肌萎縮性側索硬化的治療劑 | |
| HK1207311A1 (en) | Agent for ameliorating allergy | |
| EP2919816A4 (en) | COMBINATION TREATMENT FOR AMYOTROPHE LATERAL SCLEROSIS (ALS) | |
| EP2814479A4 (en) | METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS | |
| EP2811999A4 (en) | NOVEL CYSTEINE PROTEASE INHIBITORS AND USES THEREOF | |
| PT2874604T (pt) | Utilização de um agente quelante anfótero para a prevenção das alergias de contacto | |
| GB201223029D0 (en) | Chelating agents | |
| GB201223030D0 (en) | Chelating Agents | |
| GB201208947D0 (en) | Aspartic protease inhibitors |